Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21207 | 369 | 27.8 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
772 | 11635 | PULMONARY HYPERTENSION//PULMONARY ARTERIAL HYPERTENSION//CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VALVULOPATHY | Author keyword | 9 | 38% | 5% | 19 |
2 | DRUG INDUCED VALVULAR DISEASE | Author keyword | 9 | 83% | 1% | 5 |
3 | ERGOT DERIVED DOPAMINE AGONISTS | Author keyword | 9 | 83% | 1% | 5 |
4 | 5 HYDROXYTRYPTAMINE 2B RECEPTOR | Author keyword | 6 | 80% | 1% | 4 |
5 | PLEUROPULMONARY FIBROSIS | Author keyword | 6 | 100% | 1% | 4 |
6 | CARDIAC VALVULOPATHY | Author keyword | 4 | 67% | 1% | 4 |
7 | GRP HT BRETAGNE OCCIDENTALE | Address | 4 | 67% | 1% | 4 |
8 | ANOREXIGENS | Author keyword | 4 | 44% | 2% | 7 |
9 | PERGOLIDE | Author keyword | 4 | 14% | 7% | 27 |
10 | BENFLUOREX | Author keyword | 4 | 27% | 3% | 12 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VALVULOPATHY | 39 | 68% | 9% | 34 |
2 | 5 HT2B RECEPTORS | 28 | 45% | 13% | 47 |
3 | APPETITE SUPPRESSANT DRUGS | 26 | 42% | 13% | 47 |
4 | FENFLURAMINE PHENTERMINE | 25 | 54% | 9% | 32 |
5 | CARDIAC VALVE REGURGITATION | 21 | 52% | 8% | 29 |
6 | DERIVATIVE DOPAMINE AGONISTS | 18 | 83% | 3% | 10 |
7 | VALVE ABNORMALITIES | 15 | 71% | 3% | 12 |
8 | ERGOTAMINE THERAPY | 15 | 88% | 2% | 7 |
9 | PLEUROPULMONARY CHANGES | 13 | 69% | 3% | 11 |
10 | FENFLURAMINE | 11 | 12% | 23% | 86 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Drug-induced fibrotic valvular heart disease | 2009 | 53 | 63 | 67% |
Drug-induced valvular heart disease | 2013 | 7 | 31 | 94% |
Drug-induced valvular heart disease: An update | 2013 | 6 | 37 | 97% |
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease | 2007 | 90 | 16 | 75% |
The Risk of Valvular Regurgitation in Patients with Parkinson's Disease Treated with Dopamine Receptor Agonists | 2011 | 11 | 35 | 80% |
Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review | 2009 | 24 | 46 | 61% |
Role of echocardiography in toxic heart valvulopathy | 2009 | 11 | 97 | 89% |
Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: A meta-analysis from clinical studies | 2008 | 16 | 16 | 75% |
Serotonin receptors and heart valve disease-It was meant 2B | 2011 | 31 | 119 | 22% |
Serotonergic drugs and valvular heart disease | 2009 | 41 | 71 | 27% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP HT BRETAGNE OCCIDENTALE | 4 | 67% | 1.1% | 4 |
2 | CIC0005 | 2 | 44% | 1.1% | 4 |
3 | POLE CARDIOVASC THORAC | 1 | 38% | 0.8% | 3 |
4 | ESTABLISHED PROD BUSINESS UNIT | 1 | 100% | 0.5% | 2 |
5 | USHATE IVAN PENTCHEV | 1 | 100% | 0.5% | 2 |
6 | LTSI INSERM U642 | 1 | 40% | 0.5% | 2 |
7 | UC LILLE | 1 | 40% | 0.5% | 2 |
8 | SERV MED INTERNE CARDIOL | 1 | 17% | 1.1% | 4 |
9 | CATHOL LILLE | 1 | 50% | 0.3% | 1 |
10 | CIC9023 | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196917 | SIBUTRAMINE//ORLISTAT//ANTIOBESITY DRUGS |
2 | 0.0000114565 | DEXFENFLURAMINE//D FENFLURAMINE//FENFLURAMINE |
3 | 0.0000105742 | MOTOR FLUCTUATIONS//LEVODOPA//DYSKINESIA |
4 | 0.0000100853 | MITRAL ANNULAR CALCIFICATION//CALCIFIC AORTIC VALVE DISEASE//VALVULAR INTERSTITIAL CELLS |
5 | 0.0000094732 | MACROPROLACTIN//PROLACTINOMA//HYPERPROLACTINEMIA |
6 | 0.0000069912 | RETROPERITONEAL FIBROSIS//IDIOPATHIC RETROPERITONEAL FIBROSIS//RIEDELS THYROIDITIS |
7 | 0.0000060171 | MONOCROTALINE//PULMONARY ARTERIAL HYPERTENSION//BMPR2 |
8 | 0.0000051642 | PULMONARY ARTERIAL HYPERTENSION//TREPROSTINIL//PULMONARY HYPERTENSION |
9 | 0.0000051208 | TERGURIDE//ERGOLINE//DOPAMINE D 2 AGONIST |
10 | 0.0000046706 | HERITAGE MED 275//JCR LA CP RAT//BENFLUOREX |